Back
Elutia 10K Form
Buy
80
ELUT
Elutia
Last Price:
3.72
Seasonality Move:
59.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ELUT News And Ratings
See the #1 stock for the next 7 days that we like better than ELUT
ELUT Financial Statistics
Sales & Book Value
| Annual Sales: | $24.75M |
|---|---|
| Cash Flow: | $-4.33M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.28 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.86000 |
|---|---|
| Net Income (TTM): | $-65.24M |
| Gross Margin: | $11.05M |
| Return on Equity: | 0% |
| Return on Assets: | -143.31% |
Elutia Earnings Forecast
Key Elutia Financial Ratios
- The Gross Profit Margin over the past 6 years for ELUT is 44.67%.
- The Selling, General & Administrative Expenses for ELUT have been equal to 109.88% of Gross Profit Margin.
- The Research & Development expenses have been 17.78% of Revenue.
- The Interest Expense is -15.39% of Operating Income.
- The Net Earning history of ELUT is -152.18% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Elutia Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ELUT |
| Website: | aziyo.com |
Debt
| Debt-to-Equity Ratio: | -0.35 |
|---|---|
| Current Ratio: | 0.76 |
| Quick Ratio: | 0.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |